Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy.
Orito E, Mizokami M, Mizoguchi N, Ohba K, Tohnai M, Yamanaka H, Oguri T, Hirashima N, Koide T, Kano H, et al.
Orito E, et al. Among authors: mizokami m.
J Hepatol. 1994 Jul;21(1):130-2. doi: 10.1016/s0168-8278(94)80149-5.
J Hepatol. 1994.
PMID: 7525694
Clinical Trial.